Systematic Review of Ovarian Activity and Potential for Embryo Formation and Loss during the Use of Hormonal Contraception

  • Department of Obstetrics, Gynecology, and Women’s Health, St. Louis University, St. Louis, MO, USA ROR
  • Retired
  • Saint Louis University, Saint Louis, MO, USA
  • Duke University ROR
  • American Congress of Obstetricians and Gynecologists ROR

The Linacre Quarterly, 85(4), 453-469

DOI 10.1177/0024363918815611 PMID 32431378

Abstract

The purpose of this review was to determine whether there is evidence that ovulation can occur in women using hormonal contraceptives and whether these drugs might inhibit implantation. We performed a systematic review of the published English-language literature from 1990 to the present which included studies on the hormonal milieu following egg release in women using any hormonal contraceptive method. High circulating estrogens and progestins in the follicular phase appear to induce dysfunctional ovulation, where follicular rupture occurs but is followed by low or absent corpus luteum production of progesterone. Hoogland scoring of ovulatory activity may inadvertently obscure the reality of ovum release by limiting the term "ovulation" to those instances where follicular rupture is followed by production of a threshold level of luteal progesterone, sufficient to sustain fertilization, implantation, and the end point of a positive β-human chorionic gonadotropin. However, follicular ruptures and egg release with subsequent low progesterone output have been documented in women using hormonal contraception. In the absence of specific ovulation and fertilization markers, follicular rupture should be considered the best marker for egg release and potential fertilization. Women using hormonal contraceptives may produce more eggs than previously described by established criteria; moreover, suboptimal luteal progesterone production may be more likely than previously acknowledged, which may contribute to embryo loss. This information should be included in informed consent for women who are considering the use of hormonal contraception.

Summary

For this study, the authors looked at English-language research articles that focused on how hormonal birth control, such as the birth control pill, may affect very early human embryos. The authors found that abnormal ovulation, or release of an egg followed by abnormal hormone levels, may often occur in women using hormonal birth control. This may increase the number of very early human embryos who are lost before a pregnancy test becomes positive. For women who are thinking about using hormonal birth control, this is important information to consider.

Topics

Harrison Buskmiller Chireau ovulation hormonal contraceptives breakthrough embryo implantation, systematic review ovarian activity breakthrough ovulation hormonal contraception, endometrial receptivity hormonal contraceptive mechanism post-fertilization effect, hormonal milieu after egg release contraceptive users implantation inhibition evidence, oral contraceptive progestin-only injectable patch ring breakthrough ovulation rate, mechanism of action hormonal contraception pre-fertilization post-fertilization, embryo formation loss abortifacient potential hormonal contraceptive methods, cervical mucus endometrial thickness hormonal contraception backup mechanisms, 1990-present English literature systematic review contraceptive ovarian suppression, ethical implications hormonal contraception embryo loss informed consent
PMID 32431378 32431378 DOI 10.1177/0024363918815611 10.1177/0024363918815611

Cite this article

Harrison, D., Cara Buskmiller, Chireau, M., Ruppersberger, L. A., & Yeung PP Jr (2018). Systematic Review of Ovarian Activity and Potential for Embryo Formation and Loss during the Use of Hormonal Contraception. *The Linacre Quarterly*, *85*(4), 453-469. https://doi.org/10.1177/0024363918815611

Related articles